Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy (Q37011369)

17 August 2017

1 reference

title

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy (English)

1 reference

17 August 2017

author

Valentín Fuster Carulla

series ordinal

3

1 reference

17 August 2017

Marc A Miller

1

1 reference

17 August 2017

J Anthony Gomes

series ordinal

2

1 reference

17 August 2017

publication date

1 December 2007

1 reference

17 August 2017

number of pages

10

1 reference

Nature Clinical Practice Cardiovascular Medicine

inferred from page(s)

published in

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

667-676

1 reference

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Evaluation and management of patients after implantable cardioverter-defibrillator shock

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Vascular mechanisms of sudden death in hypertrophic cardiomyopathy, including blood pressure responses to exercise

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Nonsustained ventricular tachycardia: where do we stand?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Sustained arrhythmias in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Assessment of the diagnostic value of head-up tilt testing in the evaluation of syncope in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

A comparison of positive family history definitions for defining risk of future disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Predictors of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Sudden death due to troponin T mutations

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Does LV outflow tract obstruction increase the risk of sudden death in hypertrophic cardiomyopathy?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Clinical significance of T-wave alternans in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1057

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1057

1 reference

17 August 2017

1 reference